A research team from the Medical University of Vienna has investigated structural changes in kidneys of patients with hypertension and type 2 diabetes.

Nephrology is specialty of medicine concerned with kidney physiology, kidney disease, the treatment of kidney problems and renal replacement therapy. Systemic conditions that affect the kidneys (e ...

PRINCETON, N.J., March 19, 2025 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced the launch of Nitazoxanide Tablets, 500 mg. ANI’s Nitazoxanide Tablets ...

Nikhil Lalwani, President and CEO of ANI stated, “This transaction reflects our commitment to strengthening our Retina portfolio and maximizing the long-term value of ILUVIEN and YUTIQ. By eliminating ...

So pursue abstracted, figurative logos even if your company name remains unclear at first glimpse. Mystery gives way to awareness upon repeated exposure in patronage-building touchpoints. Generic ...

Generic versions of Ozempic could be available in Canada as early as next year, making Canadians among the first in the world to get cheaper copies of the type 2 diabetes drug that has become a ...

From its origins in a garage to becoming one of the most recognisable symbols in the world, explore the story behind the iconic Apple logo design. Apple is a company that has changed the technology ...

Drugmaker Hikma is in talks with partners across the world to prepare to sell a generic version of Ozempic and Wegovy, as patents on Novo Nordisk’s blockbuster diabetes and weight loss drugs ...

India’s top generics players like Dr Reddy’s, Sun Pharma, Biocon, Cipla and more are rushing to develop versions of GLP-1 drugs, including generic copies of Semaglutide. The drug will lose ...

has been granted an official generic name by the United States Adopted Names (USAN) Council. Rentosertib stands as the first investigational drug in which both the biological target and the ...

Generic drugs made in India cause 54% more severe adverse reactions than identical drugs made in the U.S., a study finds. The issue seems to stem from regulatory oversight differences, as FDA ...

However, while there is no clarity on the actual contours of the decision, doyens of the domestic pharmaceutical industry say levying tariffs may make generic drugs marginally costlier for the US ...